TABLE 1.

Primers.

Gene	Forward (5’-3’)	Reverse (5’-3’)
IFNα	TACTCAGCAGACCTTGAACCT	CAGTCTTGGCAGCAAGTTGAC
IFNβ	TGGGTGGAATGAGACTATTGTTG	CTCCCACGTCAATCTTTCCTC
IFNγ	ATCTGGAGGAACTGGCAAAA	TTCAAGACTTCAAAGAGTCTGAGG
IL-6	GGCCTTCCCTACTTCACAAG	ATTTCCACGATTTCCCAGAG
TNF	GACCCTCACACTCAGATCATCTTCT	CCTCCACTTGGTGGTTTGCT
IL-1β	CTGGTGTGTGACGTTCCCATTA	CCGACAGCACGAGGCTTT
TLR4	GCCTTTCAGGGAATTAAGCTCC	AGATCAACCGATGGACGTGTAA
TLR7	ATGTGGACACGGAAGAGACAA	GGTAAGGGTAAGATTGGTGGTG
β2M	TTCTGGTGCTTGTCTCACTGA	CAGTATGTTCGGCTTCCCATTC
LPL	GGGAGTTTGGCTCCAGAGTTT	TGTGTCTTCAGGGGTCCTTAG
TREM2	CTCCAGGAATCAAGAGACCTCC	CCGGGTCCAGTGAGGATCT
APOE	CTCCCAAGTCACACAAGAACTG	CCAGCTCCTTTTTGTAAGCCTTT
Ctsd	GCTTCCGGTCTTTGACAACCT	CACCAAGCATTAGTTCTCCTCC
CD68	TGTCTGATCTTGCTAGGACCG	GAGAGTAACGGCCTTTTTGTGA
TGFβ	CTCCCGTGGCTTCTAGTGC	GCCTTAGTTTGGACAGGATCTG
IRF-3	AACCGGAAAGAAGTGTTGCG	CCCTGGAGTCACAAACTCATAC
TRAIL	GGGAGTCCTCTCGGAAAGG	CCGGATAGCTGGTGTACTTGTA
Caspase 3	ATGGAGAACAACAAAACCTCAGT	TTGCTCCCATGTATGGTCTTTAC
Caspase 8	TGCTTGGACTACATCCCACAC	TGCAGTCTAGGAAGTTGACCA
β-Actin (control)	CATTGCTGACAGGATGCAGAAGG	TGCTGGAAGGTGGACAGTGAGG